Faster tests for ebola and lassa fever using stored blood samples
Part of Infections clinical trials.
This study is testing a new, faster way to detect Ebola and Lassa fever viruses using stored blood samples. Your sample could help improve diagnosis and care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a stored blood sample from a past Ebola or Lassa fever infection that has been kept in a biobank.
- The sample can be from a person who tested positive for either Ebola or Lassa fever.
- The sample can also be from a person who tested negative for these diseases (for comparison).
- You do not need to be currently sick to take part, unless you have a recent sample available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, faster way to detect Ebola in blood samples. They are using stored blood samples to see if the new test works as well as the standard one.
This trial tests different combinations of antiviral drugs (favipiravir, ribavirin, and a steroid called dexamethasone) in adults hospitalized with Lassa fever. The goal is to find the safest and most effective treatment.
This trial tests an investigational vaccine to prevent Lassa fever, a serious illness found in parts of West Africa. People in different age groups will get the vaccine or a placebo and be followed to see if it’s safe and helps the immune system respond.
This trial provides an experimental antibody treatment called REGN-EB3 to people infected with Ebola virus. It aims to treat the infection and potentially improve recovery, and is available through special access in areas with Ebola outbreaks.
This trial tests whether adding dexamethasone, a steroid that reduces inflammation, to standard care can help people with severe Lassa fever. It is for adults who are very sick with confirmed Lassa fever.
This trial is developing a quick, point-of-care diagnostic test for Crimean-Congo hemorrhagic fever (CCHF), a serious viral illness. If you have symptoms and are being tested for CCHF, this study could help confirm the diagnosis faster.
Hear when a new Ebola Hemorrhagic Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.